Human medicines European public assessment report (EPAR): Rapiscan, regadenoson, Myocardial Perfusion Imaging, Date of authorisation: 06/09/2010, Revision: 12, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Rapiscan, regadenoson, Myocardial Perfusion Imaging, Date of authorisation: 06/09/2010, Revision: 12, Status: Authorised
[automaticbacklinks]